Open Collective
Open Collective

Manifest Grants

Fast funding for translation research.


Become a financial contributor.

Financial Contributions

Custom contribution
Make a custom one-time or recurring contribution.

Latest activity by

+ 19
One-time contribution

Thank you for your contribution to accelerating female reproductive science!

Latest activity by


Support the following initiatives from Manifest Grants.

Fast funding for bio x climate science
Fast funding for female reproductive science


Transparent and open finances.

-$75.00 USD
Invoice #162384

Credit from Gitcoin Grants Round 15! to Manifest Grants

Contribution #694533
-$105.00 USD
Invoice #162295
Today’s balance

$1,024,031.50 USD

Total raised

$1,784,917.43 USD

Total disbursed

$760,885.93 USD

Estimated annual budget

$1,897,918.44 USD


Let’s get the ball rolling!

News from Manifest Grants

Updates on our activities and progress.

Fifty Years launches Repro Grants!

A light micrograph of ovarian follicles. At its peak, Viagra generated $2 billion in...
Read more
Published on December 22, 2022 by Sara Kemppainen


What causes endometriosis?  We don’t know.
Why do women go through menopause?  We don’t know.
Why are women 2x more at risk for Alzheimer’s Disease?  We don’t know.
What is the long-term impact of hormonal contraceptives?  We don’t know.

‘We don’t know’ isn’t good enough.

Repro Grants is a “fast grants” program that awards $10K-$100K to ambitious research projects aiming to deepen our understanding of the female* reproductive system. We are motivated to learn how our bodies work, so we can develop better diagnostics and interventions to improve women's health outcomes and longevity. The application form takes ~30 minutes to complete and the applicant will get a decision within 21 days of applying. 

We’re embarrassingly late.

Since the Hippocratic oath, the male body has been the “medical norm”. Only in 1993 did the NIH, the primary federal agency for supporting medical science, first mandate that clinical trials should be run on both men and women. Unfortunately, this law only applied to NIH grantees and not the pharma industry which is responsible for more than 90% of trials. This means that modern medicine is based on research almost exclusively done on male bodies, with severe implications on women’s health outcomes: 

We overmedicate women. Most drugs have a 'one-size-fits-all' dosage despite obvious sex differences e.g. body fat composition. A study found that over 96% of common drugs (like aspirin) are prescribed to women in too high doses leading to excess side effects.

We misdiagnose women. Across 700 diseases women are on average diagnosed significantly later than men. For example, a woman having a heart attack is 50% more likely to get the wrong diagnosis due to differences in symptoms and sensitivity to commonly used diagnostics.

We ignore female anatomy. It was only in 1998 that Helen O'Connell discovered that the clitoris is not just a tiny bulb at the top of the vulva but about a 10-cm long internal structure. That’s almost 30 years after humans landed on Mars! Apparently, the vulva is more inaccessible than Mars.

Although progress is evident, female-specific conditions remain secondary research subjects. Nowhere is this as clear as in the field of reproductive health. As of 2022, it takes on average 10 years to get diagnosed with endometriosis, an excruciatingly painful condition where tissue similar to the lining of the uterus (endometrium) starts to grow outside of the uterus. The cause and cure for endometriosis remain a mystery to modern medicine. 

And if you aren’t convinced yet, in the last two decades we have churned 5.5x more studies about male infertility than female infertility. Not to mention that in 2019 alone, the number of publications on male erectile dysfunction surpassed studies on female fertility by nearly 6-fold. We have centuries worth of research to catch on to properly understand how the bodies of half of the world’s population work.

Why do we need Repro Grants? 

Relatively small sums of capital are directed towards supporting fundamental research for women’s reproductive health. About 15% of all NIH funding goes to women’s health (2018 data). This capital allocation does not take into consideration or intend to correct the hundreds of years lag in women’s health research. 

Beyond the capital dilemma, the mechanisms for accessing funding are too slow. It is estimated that leading researchers spend up to 50% of their time writing grant applications. We want to offer an alternative; a fast and efficient process for getting access to crucial funding, so scientists can focus on what matters the most — doing the science. We are starting with a quick experiment; deploying $1M in Fast Grant Round 1. We will take the learnings and hope to increase the scale and velocity of the funding in future rounds.

Our team